Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. [electronic resource]
Producer: 20120815Description: 579-88 p. digitalISSN:- 1474-5488
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Capecitabine
- Chemoradiotherapy -- methods
- Cross-Over Studies
- Deoxycytidine -- analogs & derivatives
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil -- analogs & derivatives
- Follow-Up Studies
- Germany
- Humans
- Kaplan-Meier Estimate
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Patient Selection
- Radiotherapy Dosage
- Rectal Neoplasms -- mortality
- Risk Assessment
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.